136 related articles for article (PubMed ID: 3456247)
1. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia.
Nara N; Curtis JE; Senn JS; Tritchler DL; McCulloch EA
Blood; 1986 Mar; 67(3):762-9. PubMed ID: 3456247
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients.
Nara N; Suzuki T; Nagata K; Yamashita Y; Murohashi I; Adachi Y
Br J Haematol; 1988 Oct; 70(2):187-91. PubMed ID: 3191030
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia.
Yang GS; McCulloch EA
Hematol Pathol; 1992; 6(3):125-30. PubMed ID: 1385380
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity to 5-azacytidine of blast progenitors in acute myeloblastic leukemia.
Wang C; McCulloch EA
Blood; 1987 Feb; 69(2):553-9. PubMed ID: 2432971
[TBL] [Abstract][Full Text] [Related]
5. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
[TBL] [Abstract][Full Text] [Related]
6. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
[TBL] [Abstract][Full Text] [Related]
8. A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside.
Rayappa C; McCulloch EA
Leukemia; 1993 Jul; 7(7):992-9. PubMed ID: 8321050
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells.
Tohda S; Nagata K; Suzuki T; Nara N
Acta Haematol; 1990; 83(1):16-21. PubMed ID: 2105564
[TBL] [Abstract][Full Text] [Related]
10. Response to 5-azacytidine of leukemic blast cells in suspension: a biological parameter associated with response to chemotherapy.
Wang C; Curtis JE; Senn JS; Tritchler DL; McCulloch EA
Leukemia; 1987 Nov; 1(11):753-6. PubMed ID: 2446086
[TBL] [Abstract][Full Text] [Related]
11. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia.
Wang YF; Kelleher CA; Minkin S; McCulloch EA
Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468
[TBL] [Abstract][Full Text] [Related]
12. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
[TBL] [Abstract][Full Text] [Related]
13. Effects of purified human native granulocyte colony-stimulating factor (G-CSF) on proliferation of blast progenitors in acute myeloblastic leukemia.
Nara N; Murohashi I; Suzuki T; Yamashita Y; Maruyama Y; Aoki N; Tanikawa S; Onozawa Y
Am J Hematol; 1988 Feb; 27(2):84-8. PubMed ID: 3257647
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
Koistinen P; Wang C; Curtis JE; McCulloch EA
Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
[TBL] [Abstract][Full Text] [Related]
15. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.
Van der Lely N; De Witte T; Wessels J; Raymakers R; Muus P; Preijers F
Ann Hematol; 1994 May; 68(5):225-32. PubMed ID: 7517190
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity.
Yang GS; Wang C; Minden MD; McCulloch EA
Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994
[TBL] [Abstract][Full Text] [Related]
17. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside.
Viallard JF; Grosset C; Lacombe F; David S; Mahon FX; Barbot C; Vianes I; Dupouy M; Reiffers J
Leuk Res; 1996; 20(11-12):915-23. PubMed ID: 9009249
[TBL] [Abstract][Full Text] [Related]
18. The heritable nature of clonal characteristics in acute myeloblastic leukemia.
McCulloch EA; Buick RN; Curtis JE; Messner HA; Senn JS
Blood; 1981 Jul; 58(1):105-9. PubMed ID: 6940626
[TBL] [Abstract][Full Text] [Related]
19. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
20. The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia.
Nara N; McCulloch EA
Blood; 1985 Jun; 65(6):1484-93. PubMed ID: 3857945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
